Recent patient data surrounding the medication Retatrutide , specifically the 120mg formulation referred to as ZPHC, suggest a impressive benefit on weight loss and associated chronic conditions . Researchers believe that this combined agonist , influencing both GLP-1 and GIP pathways , could represent a major breakthrough in the approach of overwe